> top > docs > PMC:7260509 > annotations

PMC:7260509 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 12-16 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T2 1561-1565 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T3 1698-1705 Body_part denotes Capsule http://purl.org/sig/ont/fma/fma85272
T4 2604-2608 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T5 3863-3867 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T6 4867-4871 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T7 5984-5988 Body_part denotes Body http://purl.org/sig/ont/fma/fma256135
T8 6004-6008 Body_part denotes Foot http://purl.org/sig/ont/fma/fma9664
T9 6052-6056 Body_part denotes Hand http://purl.org/sig/ont/fma/fma9712
T10 7213-7219 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T11 7682-7686 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T12 7861-7866 Body_part denotes bowel http://purl.org/sig/ont/fma/fma7199
T13 8035-8043 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T14 8463-8471 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T15 8509-8517 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T16 8582-8590 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T17 8613-8627 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T18 8628-8633 Body_part denotes (Ig)M http://purl.org/sig/ont/fma/fma62873
T19 8629-8631 Body_part denotes Ig http://purl.org/sig/ont/fma/fma62871
T20 8647-8650 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T21 8714-8717 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T22 8731-8734 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T23 8744-8752 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T24 8847-8855 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T25 9642-9650 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T26 9798-9804 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T27 10788-10792 Body_part denotes toes http://purl.org/sig/ont/fma/fma70664
T28 10801-10808 Body_part denotes fingers http://purl.org/sig/ont/fma/fma9666
T29 10886-10894 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T30 11137-11148 Body_part denotes lymphocytic http://purl.org/sig/ont/fma/fma62863
T31 11189-11206 Body_part denotes connective tissue http://purl.org/sig/ont/fma/fma9640
T32 11445-11458 Body_part denotes keratinocytes http://purl.org/sig/ont/fma/fma62879
T33 11577-11588 Body_part denotes lymphocytic http://purl.org/sig/ont/fma/fma62863
T34 11711-11722 Body_part denotes lymphocytic http://purl.org/sig/ont/fma/fma62863
T35 11776-11787 Body_part denotes lymphocytic http://purl.org/sig/ont/fma/fma62863
T36 12527-12531 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T37 13603-13607 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T38 14615-14623 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T39 14752-14760 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T40 14770-14773 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T41 14775-14778 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T42 14877-14880 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T43 14929-14937 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T44 14962-14965 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T45 14990-14993 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T46 15076-15079 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T47 15169-15177 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T48 15406-15414 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T49 15443-15446 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T50 15629-15637 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T51 15813-15817 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T52 15904-15907 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T53 15911-15914 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T54 16691-16699 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T55 16760-16768 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T56 16942-16950 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T57 17175-17179 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T58 17207-17210 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T59 17216-17219 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T60 17593-17601 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T61 18068-18079 Body_part denotes lymphocytic http://purl.org/sig/ont/fma/fma62863
T62 19780-19784 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T63 19934-19938 Body_part denotes skin http://purl.org/sig/ont/fma/fma7163
T64 20222-20225 Body_part denotes IgM http://purl.org/sig/ont/fma/fma62873
T65 20230-20233 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T66 20809-20817 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 12-16 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T2 1561-1565 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T3 1581-1585 Body_part denotes feet http://purl.obolibrary.org/obo/UBERON_0002387
T4 1590-1595 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T5 1698-1705 Body_part denotes Capsule http://purl.obolibrary.org/obo/UBERON_0003893
T6 2604-2608 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T7 3863-3867 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T8 4867-4871 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T9 6004-6008 Body_part denotes Foot http://purl.obolibrary.org/obo/UBERON_0002387
T10 6052-6056 Body_part denotes Hand http://purl.obolibrary.org/obo/UBERON_0002398
T11 7213-7219 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T12 7682-7686 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T13 9798-9804 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T14 10412-10416 Body_part denotes feet http://purl.obolibrary.org/obo/UBERON_0002387
T15 10446-10451 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T16 10486-10491 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T17 10496-10500 Body_part denotes feet http://purl.obolibrary.org/obo/UBERON_0002387
T18 10801-10808 Body_part denotes fingers http://purl.obolibrary.org/obo/UBERON_0002389
T19 11189-11206 Body_part denotes connective tissue http://purl.obolibrary.org/obo/UBERON_0002384
T20 11200-11206 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T21 11704-11710 Body_part denotes vessel http://purl.obolibrary.org/obo/UBERON_0000055
T22 12527-12531 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T23 13603-13607 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T24 15813-15817 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T25 17175-17179 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T26 19780-19784 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014
T27 19934-19938 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T90 14606-14614 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T91 14693-14701 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 14950-14958 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T93 15266-15274 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T94 15556-15564 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 15730-15738 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T96 16043-16051 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T97 16181-16189 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 16391-16399 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T99 16663-16671 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T100 17076-17085 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T101 17091-17095 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T102 17193-17201 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T103 17444-17452 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T104 17544-17572 Disease denotes systemic lupus erythematosus http://purl.obolibrary.org/obo/MONDO_0007915
T105 17553-17572 Disease denotes lupus erythematosus http://purl.obolibrary.org/obo/MONDO_0004670
T106 17576-17610 Disease denotes antiphospholipid antibody syndrome http://purl.obolibrary.org/obo/MONDO_0007140
T107 17716-17724 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T108 17790-17798 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T109 17893-17901 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T110 18002-18010 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T111 18068-18090 Disease denotes lymphocytic vasculitis http://purl.obolibrary.org/obo/MONDO_0008640
T112 18080-18090 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T113 18191-18206 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T114 18197-18206 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T115 18351-18363 Disease denotes coagulopathy http://purl.obolibrary.org/obo/MONDO_0001531
T116 18410-18418 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T117 18440-18462 Disease denotes venous thromboembolism http://purl.obolibrary.org/obo/MONDO_0005399
T118 18500-18510 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T119 18915-18933 Disease denotes hypercoagulability http://purl.obolibrary.org/obo/MONDO_0002305
T120 18950-18958 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T121 19033-19041 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T122 19062-19068 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T124 19139-19146 Disease denotes strokes http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T126 19213-19221 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T127 19815-19823 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T128 19862-19870 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T129 19884-19894 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T130 20002-20010 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T131 20160-20168 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T132 20458-20461 Disease denotes Drs http://purl.obolibrary.org/obo/MONDO_0024265
T133 20577-20580 Disease denotes Drs http://purl.obolibrary.org/obo/MONDO_0024265
T134 20907-20915 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T135 21152-21160 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T136 21292-21295 Disease denotes Drs http://purl.obolibrary.org/obo/MONDO_0024265
T1 41-49 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 212-230 Disease denotes infectious disease http://purl.obolibrary.org/obo/MONDO_0005550
T3 237-245 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 367-375 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 677-685 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 822-830 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 876-884 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 933-941 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 1018-1026 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 1081-1089 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 1195-1203 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1638-1646 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 1647-1656 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T14 1859-1867 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 1995-2005 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T16 2021-2029 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 2102-2120 Disease denotes infectious disease http://purl.obolibrary.org/obo/MONDO_0005550
T18 2127-2135 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 2208-2216 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 2354-2370 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T21 2827-2835 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 3023-3031 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 3119-3127 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 3736-3744 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 3917-3925 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 4317-4325 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 4538-4546 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 4815-4823 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T29 4888-4896 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T30 4946-4954 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 4984-4992 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T32 5022-5030 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T33 6370-6378 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 6436-6444 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T35 6514-6522 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T36 6574-6582 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T37 6684-6692 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T38 6814-6822 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T39 6875-6883 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 6963-6971 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 6972-6982 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T42 7042-7050 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 7208-7219 Disease denotes Sore throat http://purl.obolibrary.org/obo/MONDO_0002258
T44 7414-7422 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T45 7670-7694 Disease denotes Obstructive lung disease http://purl.obolibrary.org/obo/MONDO_0002267
T46 7682-7694 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T47 7737-7749 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T48 7848-7880 Disease denotes Inflammatory bowel disease … … 6 http://purl.obolibrary.org/obo/MONDO_0011700
T49 7848-7874 Disease denotes Inflammatory bowel disease http://purl.obolibrary.org/obo/MONDO_0005265
T50 8026-8034 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 8135-8143 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T52 8384-8392 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T53 8947-8955 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T54 9078-9086 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T55 9137-9145 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 9404-9451 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T57 9404-9437 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T58 9453-9461 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T59 9488-9496 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T60 9667-9675 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T61 9793-9804 Disease denotes sore throat http://purl.obolibrary.org/obo/MONDO_0002258
T62 9947-9955 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T63 9994-10002 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T64 10825-10833 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T65 10943-10951 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T66 11094-11104 Disease denotes dermatitis http://purl.obolibrary.org/obo/MONDO_0002406
T67 11149-11161 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T68 11189-11214 Disease denotes connective tissue disease http://purl.obolibrary.org/obo/MONDO_0003900|http://purl.obolibrary.org/obo/MONDO_0005554
T70 11642-11652 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T71 11711-11733 Disease denotes lymphocytic vasculitis http://purl.obolibrary.org/obo/MONDO_0008640
T72 11723-11733 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T73 11776-11798 Disease denotes lymphocytic vasculitis http://purl.obolibrary.org/obo/MONDO_0008640
T74 11788-11798 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T75 12086-12094 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T76 12211-12220 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T77 12417-12425 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T78 12486-12494 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T79 12639-12647 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T80 12745-12753 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T81 12884-12892 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 12995-13003 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 13131-13140 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T84 13233-13241 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T85 13282-13290 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T86 13571-13579 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 14071-14079 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T88 14176-14184 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T89 14430-14438 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 12-16 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T2 12-16 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T3 12-16 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T4 12-16 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T5 12-16 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T6 51-52 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T7 249-258 http://purl.obolibrary.org/obo/BFO_0000030 denotes Objective
T8 577-590 http://purl.obolibrary.org/obo/OBI_0000245 denotes organizations
T9 1042-1049 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T10 1090-1097 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T11 1302-1303 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 1370-1371 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T13 1561-1565 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T14 1561-1565 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T15 1561-1565 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T16 1561-1565 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T17 1561-1565 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T18 1688-1695 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T19 1830-1831 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 2030-2037 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T21 2137-2140 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T22 2439-2440 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 2506-2511 http://purl.obolibrary.org/obo/CLO_0053799 denotes 4 , 5
T24 2538-2539 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T25 2604-2608 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T26 2604-2608 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T27 2604-2608 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T28 2604-2608 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T29 2604-2608 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T30 2898-2908 http://purl.obolibrary.org/obo/BFO_0000030 denotes objectives
T31 3088-3089 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T32 3547-3548 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T33 3863-3867 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T34 3863-3867 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T35 3863-3867 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T36 3863-3867 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T37 3863-3867 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T38 4204-4209 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes Human
T39 4867-4871 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T40 4867-4871 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T41 4867-4871 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T42 4867-4871 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T43 4867-4871 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T44 5083-5085 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T45 5116-5118 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T46 5123-5125 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T47 5138-5144 http://purl.obolibrary.org/obo/UBERON_0003100 denotes Female
T48 5150-5152 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T49 5154-5156 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T50 5170-5172 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T51 5214-5216 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T52 5226-5228 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T53 5295-5297 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T54 5461-5463 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T55 5494-5497 http://purl.obolibrary.org/obo/CLO_0001230 denotes 293
T56 5494-5497 http://purl.obolibrary.org/obo/CLO_0037237 denotes 293
T57 5494-5497 http://purl.obolibrary.org/obo/CLO_0050903 denotes 293
T58 5494-5497 http://purl.obolibrary.org/obo/CLO_0054249 denotes 293
T59 5494-5497 http://purl.obolibrary.org/obo/CLO_0054250 denotes 293
T60 5494-5497 http://purl.obolibrary.org/obo/CLO_0054251 denotes 293
T61 5494-5497 http://purl.obolibrary.org/obo/CLO_0054252 denotes 293
T62 5543-5545 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T63 5889-5892 http://purl.obolibrary.org/obo/CLO_0037284 denotes C 4
T64 5893-5899 http://purl.obolibrary.org/obo/CLO_0054057 denotes (18) 1
T65 5958-5961 http://purl.obolibrary.org/obo/CLO_0001003 denotes 163
T66 5963-5965 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T67 5980-5982 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T68 6030-6032 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T69 6047-6049 http://purl.obolibrary.org/obo/CLO_0001527 denotes 94
T70 6074-6080 http://purl.obolibrary.org/obo/CLO_0001079 denotes (14) 8
T71 6086-6088 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T72 6147-6153 http://purl.obolibrary.org/obo/CLO_0001046 denotes (11) 6
T73 6159-6161 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T74 6163-6165 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T75 6206-6208 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T76 6209-6217 http://purl.obolibrary.org/obo/CLO_0001481 denotes (76) 211
T77 6236-6238 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T78 6243-6245 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T79 6322-6324 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T80 6454-6456 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T81 6458-6460 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T82 6469-6471 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T83 6472-6479 http://purl.obolibrary.org/obo/CLO_0001176 denotes (22) 15
T84 6555-6557 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T85 6595-6597 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T86 6607-6610 http://purl.obolibrary.org/obo/CLO_0054061 denotes 132
T87 6766-6768 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T88 6887-6889 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T89 6901-6907 http://purl.obolibrary.org/obo/CLO_0001046 denotes (11) 6
T90 6934-6935 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T91 7033-7035 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T92 7077-7079 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T93 7102-7104 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T94 7136-7138 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T95 7140-7142 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T96 7184-7186 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T97 7223-7225 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T98 7280-7282 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T99 7291-7298 http://purl.obolibrary.org/obo/CLO_0001174 denotes (20) 37
T100 7459-7461 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T101 7486-7488 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T102 7652-7654 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T103 7682-7686 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T104 7682-7686 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T105 8133-8134 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T106 8344-8351 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T107 8472-8479 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T108 8518-8525 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T109 8591-8598 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T110 8777-8783 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T111 8805-8816 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing was
T112 8993-8999 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T113 9054-9060 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T114 9167-9174 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T115 9178-9179 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T116 9198-9205 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T117 9228-9235 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T118 9537-9544 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T119 9701-9703 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T120 10319-10320 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T121 10465-10466 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T122 10783-10784 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T123 10813-10814 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T124 10919-10920 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T125 11189-11206 http://purl.obolibrary.org/obo/UBERON_0002384 denotes connective tissue
T126 11189-11206 http://www.ebi.ac.uk/efo/EFO_0000952 denotes connective tissue
T127 11366-11371 http://purl.obolibrary.org/obo/CLO_0053733 denotes (1) 1
T128 11445-11458 http://purl.obolibrary.org/obo/CL_0000312 denotes keratinocytes
T129 11670-11671 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T130 11704-11710 http://purl.obolibrary.org/obo/UBERON_0000055 denotes vessel
T131 11760-11765 http://purl.obolibrary.org/obo/CLO_0053794 denotes (4) 1
T132 12034-12035 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T133 12179-12185 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T134 12527-12531 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T135 12527-12531 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T136 12527-12531 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T137 12527-12531 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T138 12527-12531 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T139 12566-12567 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T140 12724-12731 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T141 12974-12975 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T142 13222-13228 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T143 13295-13302 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T144 13397-13404 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T145 13437-13444 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T146 13445-13448 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T147 13500-13507 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T148 13603-13607 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T149 13603-13607 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T150 13603-13607 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T151 13603-13607 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T152 13603-13607 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T153 13787-13788 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T154 14213-14217 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T155 14234-14241 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T156 14312-14313 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T157 14453-14454 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T158 14476-14481 http://purl.obolibrary.org/obo/CLO_0053799 denotes 4 , 5
T159 14624-14631 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T160 14761-14768 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T161 14816-14822 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T162 15057-15058 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T163 15102-15103 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T164 15178-15185 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T165 15305-15306 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T166 15351-15352 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T167 15415-15422 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T168 15447-15454 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T169 15602-15606 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T170 15638-15645 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T171 15813-15817 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T172 15813-15817 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T173 15813-15817 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T174 15813-15817 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T175 15813-15817 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T176 16368-16369 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T177 16422-16423 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T178 16435-16436 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T179 16492-16496 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T180 16593-16598 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T181 16681-16682 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T182 16951-16958 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T183 17121-17128 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T184 17175-17179 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T185 17175-17179 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T186 17175-17179 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T187 17175-17179 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T188 17175-17179 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T189 17220-17227 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T190 17672-17674 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T191 18221-18222 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T192 18371-18372 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T193 18666-18667 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T194 18940-18941 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T195 19201-19208 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T196 19780-19784 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T197 19780-19784 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T198 19780-19784 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T199 19780-19784 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T200 19780-19784 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T201 19796-19797 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T202 19904-19905 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T203 19934-19938 http://purl.obolibrary.org/obo/UBERON_0000014 denotes skin
T204 19934-19938 http://purl.obolibrary.org/obo/UBERON_0001003 denotes skin
T205 19934-19938 http://purl.obolibrary.org/obo/UBERON_0002097 denotes skin
T206 19934-19938 http://purl.obolibrary.org/obo/UBERON_0002199 denotes skin
T207 19934-19938 http://www.ebi.ac.uk/efo/EFO_0000962 denotes skin
T208 20139-20146 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T209 20197-20204 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T210 20458-20461 http://purl.obolibrary.org/obo/CLO_0002819 denotes Drs
T211 20577-20580 http://purl.obolibrary.org/obo/CLO_0002819 denotes Drs
T212 20818-20825 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T213 21292-21295 http://purl.obolibrary.org/obo/CLO_0002819 denotes Drs
T214 21624-21627 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T215 21849-21854 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes Human

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 3455-3463 Chemical denotes medicine http://purl.obolibrary.org/obo/CHEBI_23888
T2 8104-8109 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T3 10170-10176 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T4 18168-18178 Chemical denotes interferon http://purl.obolibrary.org/obo/CHEBI_52999
T5 21408-21411 Chemical denotes AAD http://purl.obolibrary.org/obo/CHEBI_73317
T6 21565-21568 Chemical denotes AAD http://purl.obolibrary.org/obo/CHEBI_73317
T7 21604-21607 Chemical denotes AAD http://purl.obolibrary.org/obo/CHEBI_73317

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 2354-2370 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T2 11149-11161 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T3 11846-11854 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T4 11846-11854 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T5 11846-11854 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T6 11846-11854 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T7 13405-13416 http://purl.obolibrary.org/obo/GO_0065007 denotes regulations
T8 18191-18206 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-50 Sentence denotes Pernio-like skin lesions associated with COVID-19:
T2 51-97 Sentence denotes A case series of 318 patients from 8 countries
T3 99-107 Sentence denotes Abstract
T4 108-118 Sentence denotes Background
T5 119-247 Sentence denotes Increasing evidence suggests pernio-like lesions are cutaneous manifestations of coronavirus infectious disease 2019 (COVID-19).
T6 249-258 Sentence denotes Objective
T7 259-376 Sentence denotes To describe clinical and pathologic findings of pernio-like lesions in patients with confirmed or suspected COVID-19.
T8 378-385 Sentence denotes Methods
T9 386-591 Sentence denotes An international dermatology registry was circulated to health care providers worldwide through the American Academy of Dermatology, International League of Dermatologic Societies, and other organizations.
T10 593-600 Sentence denotes Results
T11 601-732 Sentence denotes We documented 505 patients with dermatologic manifestations associated with COVID-19, including 318 (63%) with pernio-like lesions.
T12 733-831 Sentence denotes Patients with pernio-like lesions were generally young and healthy, with relatively mild COVID-19.
T13 832-1027 Sentence denotes Of 318 patients with confirmed or suspected COVID-19 by providers, 23 (7%) were laboratory-confirmed COVID-19 positive, and 20 others (6%) were close contacts of patients with confirmed COVID-19.
T14 1028-1105 Sentence denotes Given current testing criteria, many patients lacked COVID-19 testing access.
T15 1106-1171 Sentence denotes For 55% of patients, pernio-like lesions were their only symptom.
T16 1172-1274 Sentence denotes In patients with other COVID-19 symptoms, pernio-like lesions typically appeared after other symptoms.
T17 1275-1356 Sentence denotes Pernio-like lesions lasted a median of 14 days (interquartile range, 10-21 days).
T18 1358-1369 Sentence denotes Limitations
T19 1370-1441 Sentence denotes A case series cannot estimate population-level incidence or prevalence.
T20 1442-1499 Sentence denotes In addition, there may be confirmation bias in reporting.
T21 1500-1535 Sentence denotes We cannot exclude an epiphenomenon.
T22 1537-1548 Sentence denotes Conclusions
T23 1549-1696 Sentence denotes Pernio-like skin changes of the feet and hands, without another explanation, may suggest COVID-19 infection and should prompt confirmatory testing.
T24 1698-1713 Sentence denotes Capsule Summary
T25 1714-1868 Sentence denotes • This large international registry-based case series adds to the emerging evidence that pernio-like lesions may be a cutaneous manifestation of COVID-19.
T26 1869-1943 Sentence denotes • Patients with pernio-like lesions generally had benign clinical courses.
T27 1944-2057 Sentence denotes Importantly, because some of these patients may be infectious, isolation and COVID-19 testing must be considered.
T28 2058-2180 Sentence denotes Emerging evidence suggests that coronavirus infectious disease 2019 (COVID-19) has associated dermatologic manifestations.
T29 2181-2893 Sentence denotes Many cutaneous findings of COVID-19 are nonspecific, such as morbilliform exanthems, urticarial eruptions, and vesicular lesions, and are often seen in the context of other viral infections.1, 2, 3 In contrast, recent reports from around the globe highlight a striking pernio-like phenomenon in association with COVID-19.1 , 4 , 5 Pernio, or chilblains, is a superficial inflammatory vascular response that occurs on acral skin, usually after cold exposure, typically in children and young to middle-aged women.6 In this large international registry-based case series, we evaluate clinical characteristics of patients with suspected or confirmed COVID-19 who presented with pernio-like lesions on acral surfaces.
T30 2894-3063 Sentence denotes Our objectives were to assess location, timing, and duration of the pernio-like lesions, and to analyze patients' comorbidities, COVID-19 severity, and disease outcomes.
T31 3065-3072 Sentence denotes Methods
T32 3073-3251 Sentence denotes We established a registry to collect cases of COVID-19 with dermatologic manifestations reported by medical professionals, with data collected from April 8, 2020, to May 2, 2020.
T33 3252-3487 Sentence denotes The registry was widely promoted to members of the American Academy of Dermatology, major dermatology subspecialty groups, the International League of Dermatologic Societies, and dermatology and general medicine groups on social media.
T34 3488-3669 Sentence denotes The website (www.aad.org/covidregistry) was hosted through a Massachusetts General Hospital REDCap (Research Electronic Data Capture, Vanderbilt University, Nashville, TN) database.
T35 3670-3792 Sentence denotes The registry queried patient demographics, dermatologic symptoms, COVID-19 history and symptoms, and past medical history.
T36 3793-3977 Sentence denotes For this subanalysis, we included patients with new-onset pernio-like skin changes in the setting of confirmed or suspected COVID-19 and excluded patients with prior history of pernio.
T37 3978-4078 Sentence denotes The deidentified patient data was analyzed using Stata 16 software (StataCorp, College Station, TX).
T38 4079-4228 Sentence denotes The registry was reviewed by Partners Healthcare Institutional Review Board and was determined to not meet the definition of Human Subjects Research.
T39 4230-4237 Sentence denotes Results
T40 4238-4430 Sentence denotes The registry compiled 505 cases of dermatologic manifestations associated with COVID-19 over 25 days, reported by dermatologists (50%), other physicians (37%), and midlevel practitioners (8%).
T41 4431-4558 Sentence denotes There were 318 patients (63%) identified with pernio-like changes in the setting of confirmed or suspected COVID-19 (Table I ).
T42 4559-4704 Sentence denotes Patients were generally young and healthy, with median age of 25 years (interquartile range, 17-38 years), including 93 children and adolescents.
T43 4705-4740 Sentence denotes Only 25% had medical comorbidities.
T44 4741-4871 Sentence denotes Table I Clinical characteristics of patients with confirmed and suspected COVID-19 who developed pernio-like lesions on acral skin
T45 4872-5071 Sentence denotes Characteristic∗ COVID-19 laboratory positive (n = 23)† Close contact with COVID-19 laboratory positive (n = 20) COVID-19 clinical suspicion (n = 229) COVID-19 PCR negative‡ (n = 46) Overall (n = 318)
T46 5072-5137 Sentence denotes Age, years 41 (23-57) 24 (17-37) 24 (17-37) 27 (16-36) 25 (17-38)
T47 5138-5190 Sentence denotes Female sex§ 11 (48) 5 (25) 118 (52) 21 (46) 155 (49)
T48 5191-5206 Sentence denotes Race/ethnicity‖
T49 5207-5255 Sentence denotes  White 18 (86) 17 (94) 195 (91) 38 (83) 268 (89)
T50 5256-5303 Sentence denotes  Asian 1 (4.8) 1 (5.6) 14 (6.5) 6 (13) 22 (7.3)
T51 5304-5367 Sentence denotes  Black/African American 0 (0.0) 0 (0.0) 1 (0.5) 1 (2.2) 2 (0.7)
T52 5368-5424 Sentence denotes  Hispanic/Latino 2 (9.5) 0 (0.0) 5 (2.3) 1 (2.2) 8 (2.7)
T53 5425-5445 Sentence denotes Country of residence
T54 5446-5502 Sentence denotes  United States 22 (96) 17 (85) 212 (93) 42 (91) 293 (92)
T55 5503-5551 Sentence denotes  Canada 0 (0.0) 1 (5.0) 6 (2.6) 4 (8.7) 11 (3.5)
T56 5552-5599 Sentence denotes  France 0 (0.0) 1 (5.0) 4 (1.8) 0 (0.0) 5 (1.6)
T57 5600-5655 Sentence denotes  United Kingdom 1 (4.3) 1 (5.0) 2 (0.9) 0 (0.0) 4 (1.3)
T58 5656-5702 Sentence denotes  Italy 0 (0.0) 0 (0.0) 1 (0.4) 0 (0.0) 1 (0.3)
T59 5703-5750 Sentence denotes  Mexico 0 (0.0) 0 (0.0) 1 (0.4) 0 (0.0) 1 (0.3)
T60 5751-5803 Sentence denotes  Netherlands 0 (0.0) 0 (0.0) 1 (0.4) 0 (0.0) 1 (0.3)
T61 5804-5849 Sentence denotes  Iran 0 (0.0) 0 (0.0) 1 (0.4) 0 (0.0) 1 (0.3)
T62 5850-5878 Sentence denotes Average monthly temperature‖
T63 5879-5929 Sentence denotes  Above 10°C 4 (18) 1 (5.0) 66 (29) 20 (43) 91 (29)
T64 5930-5983 Sentence denotes  Below 10°C 19 (82) 19 (95) 163 (71) 26 (57) 227 (71)
T65 5984-6002 Sentence denotes Body site affected
T66 6003-6050 Sentence denotes  Foot 20 (87) 19 (95) 216 (94) 43 (93) 298 (94)
T67 6051-6093 Sentence denotes  Hand 7 (30) 2 (10) 31 (14) 8 (17) 48 (15)
T68 6094-6115 Sentence denotes Dermatologic symptoms
T69 6116-6166 Sentence denotes  Asymptomatic 4 (17) 2 (10) 24 (11) 6 (13) 36 (11)
T70 6167-6222 Sentence denotes  Pain/burning 16 (70) 16 (80) 144 (63) 35 (76) 211 (66)
T71 6223-6271 Sentence denotes  Pruritus 8 (35) 9 (45) 99 (43) 21 (46) 137 (43)
T72 6272-6330 Sentence denotes  Cold intolerance 2 (8.7) 2 (10) 17 (7.4) 1 (2.2) 22 (6.9)
T73 6331-6361 Sentence denotes Timing of dermatologic changes
T74 6362-6428 Sentence denotes  Before COVID-19 symptoms 4 (17) 0 (0.0) 12 (5.4) 3 (6.5) 19 (6.1)
T75 6429-6492 Sentence denotes  After COVID-19 symptoms 11 (48) 6 (30) 48 (22) 15 (33) 80 (26)
T76 6493-6563 Sentence denotes  At the same time as COVID-19 3 (13) 1 (5.0) 14 (6.3) 4 (8.7) 22 (7.1)
T77 6564-6632 Sentence denotes  No other COVID-19 symptoms 5 (22) 12 (60) 132 (59) 21 (46) 170 (55)
T78 6633-6683 Sentence denotes  Unknown 0 (0.0) 1 (5.0) 17 (7.6) 3 (6.5) 21 (6.7)
T79 6684-6701 Sentence denotes COVID-19 exposure
T80 6702-6769 Sentence denotes  None (community acquired) 7 (30) 0 (0.0) 126 (55) 20 (43) 153 (48)
T81 6770-6802 Sentence denotes  Close contact with patient with
T82 6803-6863 Sentence denotes  Confirmed COVID-19 3 (13) 20 (100) 0 (0.0) 1 (2.1) 24 (7.5)
T83 6864-6920 Sentence denotes  Suspected COVID-19 8 (35) 4 (20) 26 (11) 6 (13) 44 (14)
T84 6921-7041 Sentence denotes  Presence in a health care facility where COVID-19 infections have been managed 1 (4.3) 0 (0.0) 10 (4.4) 7 (15) 18 (5.7)
T85 7042-7059 Sentence denotes COVID-19 symptoms
T86 7060-7114 Sentence denotes  Asymptomatic 5 (22) 10 (50) 140 (61) 19 (41) 174 (55)
T87 7115-7159 Sentence denotes  Cough 9 (39) 3 (15) 41 (18) 14 (30) 67 (21)
T88 7160-7206 Sentence denotes  Headache 7 (30) 4 (20) 27 (12) 9 (20) 47 (15)
T89 7207-7257 Sentence denotes  Sore throat 5 (22) 4 (20) 21 (9.2) 8 (17) 38 (12)
T90 7258-7303 Sentence denotes  Fever 9 (39) 1 (5.0) 18 (7.9) 9 (20) 37 (12)
T91 7304-7352 Sentence denotes  Malaise 4 (17) 1 (5.0) 20 (8.7) 6 (13) 31 (9.7)
T92 7353-7413 Sentence denotes  Shortness of breath 6 (26) 1 (5.0) 16 (7.0) 6 (13) 29 (9.1)
T93 7414-7436 Sentence denotes COVID-19 level of care
T94 7437-7502 Sentence denotes  Outpatient care only 18 (78) 20 (100) 229 (100) 45 (98) 312 (98)
T95 7503-7550 Sentence denotes  Hospitalized, alive 3 (13) … … 1 (2.2) 4 (1.3)
T96 7551-7592 Sentence denotes  Hospitalized, died 2 (8.7) … … … 2 (0.6)
T97 7593-7620 Sentence denotes Comorbid medical conditions
T98 7621-7668 Sentence denotes  None 17 (74) 12 (60) 172 (75) 36 (78) 237 (75)
T99 7669-7735 Sentence denotes  Obstructive lung disease 2 (8.7) 2 (10) 12 (5.2) 1 (2.2) 17 (5.3)
T100 7736-7789 Sentence denotes  Hypertension 2 (8.7) 1 (5.0) 5 (2.2) 1 (2.2) 9 (2.8)
T101 7790-7846 Sentence denotes  Rheumatologic disease 2 (8.7) … 3 (1.3) 3 (6.5) 8 (2.5)
T102 7847-7902 Sentence denotes  Inflammatory bowel disease … … 6 (2.6) 1 (2.2) 7 (2.2)
T103 7903-7934 Sentence denotes PCR, Polymerase chain reaction.
T104 7935-8005 Sentence denotes ∗ Data are presented as number (%) or as median (interquartile range).
T105 8006-8081 Sentence denotes † Two patients were COVID-19 antibody positive but polymerase PCR negative.
T106 8082-8172 Sentence denotes ‡ One patient in this group had close contact with a COVID-19 laboratory positive patient.
T107 8173-8208 Sentence denotes § Defined as sex assigned at birth.
T108 8209-8332 Sentence denotes ‖ Calculated using state monthly averages in the United States and country monthly averages for the other countries listed.
T109 8333-8550 Sentence denotes Laboratory testing confirmed 23 patients (7%) were COVID-19 positive, including 13 by polymerase chain reaction (PCR) alone, 5 by antibody testing alone, 1 by combined PCR and antibody testing, and 4 by unknown assay.
T110 8551-8707 Sentence denotes Of the 5 patients confirmed by antibody testing alone, 2 were immunoglobulin (Ig)M positive and IgG negative, with other patients' antibodies not specified.
T111 8708-8800 Sentence denotes The 2 IgM-positive and IgG-negative antibody-confirmed patients both tested negative by PCR.
T112 8801-8874 Sentence denotes PCR testing was not available for the other 3 antibody-positive patients.
T113 8875-9087 Sentence denotes In addition, 20 patients had close contact with patients with confirmed COVID-19 (eg, child of health care worker who tested positive); though in 1 case, the patient subsequently tested PCR negative for COVID-19.
T114 9088-9245 Sentence denotes Most cases (72%) were in patients with suspected COVID-19 without confirmatory testing at a time with limited testing access due to current testing criteria.
T115 9246-9506 Sentence denotes These cases represent novel cases of new-onset pernio in patients without prior history, temporally associated with high levels of undetected community-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) circulation during the COVID-19 pandemic.
T116 9507-9660 Sentence denotes Some patients who did receive testing had negative results: of 318 patients with pernio-like lesions, 46 were PCR negative and 14 were antibody negative.
T117 9661-9742 Sentence denotes Other COVID-19 symptoms were present in 45% of patients with pernio-like lesions.
T118 9743-9828 Sentence denotes The most common were cough (21%), headache (15%), sore throat (12%), and fever (12%).
T119 9829-9965 Sentence denotes When symptoms were present, the pernio-like lesions occurred before (13%), at the same time (15%), or after (54%) the COVID-19 symptoms.
T120 9966-10066 Sentence denotes Patients generally had mild COVID-19 clinical courses, with 6 patients hospitalized, 2 of whom died.
T121 10067-10225 Sentence denotes Of the 4 surviving hospitalized patients, 2 had uncomplicated courses, 1 patient required supplemental oxygen, and 1 required invasive mechanical ventilation.
T122 10226-10373 Sentence denotes For 42 patients with the full course of pernio observed by providers, the lesions lasted for a median of 14 days (interquartile range, 10-21 days).
T123 10374-10517 Sentence denotes Pernio-like lesions affected only the feet in 84% of patients, only the hands in 5.1%, and a combination of the hands and feet in 10% (Fig 1 ).
T124 10518-10590 Sentence denotes Associated acrocyanosis was seen in 9.2% and acral desquamation in 4.4%.
T125 10591-10748 Sentence denotes Notably, 29% of patients lived in geographic regions with average March 2020 temperatures above 10°C, temperatures at which idiopathic pernio is less likely.
T126 10749-10996 Sentence denotes Fig 1 Pernio-like lesions on the (A-F) toes and (G) fingers in (A, C, D, E) COVID-19 polymerase chain reaction-positive patients, (E, F) antibody-positive patients, and (B, G) close contacts of COVID-19 polymerase chain reaction-positive patients.
T127 10997-11215 Sentence denotes Dermatopathology was available for 1 PCR-positive patient, demonstrating mild vacuolar interface dermatitis with dense superficial and deep lymphocytic inflammation, consistent with pernio vs connective tissue disease.
T128 11216-11238 Sentence denotes No thrombi were noted.
T129 11239-11855 Sentence denotes Six other pathology reports from patients without laboratory confirmation showed findings consistent with pernio-like changes: (1) 1 with mild spongiosis, vacuolar interface change, few apoptotic epidermal keratinocytes, and perivascular and perieccrine lymphoid infiltrate, (2) 3 reporting superficial and deep perivascular, perieccrine lymphocytic or lymphohistiocytic infiltrate, without evidence of vasculitis, (3) 1 reporting a subepidermal blister with small vessel lymphocytic vasculitis without microthrombi, and (4) 1 reporting lymphocytic vasculitis with rare microthrombi and overlying epidermal necrosis.
T130 11857-11867 Sentence denotes Discussion
T131 11868-12095 Sentence denotes Our registry-based, international collaborative series of patients presents the largest and most comprehensive collection of cases reported of pernio-like lesions as a cutaneous manifestation of confirmed or suspected COVID-19.
T132 12096-12221 Sentence denotes Based on these data, we propose that this finding should prompt evaluation for the active or convalescent phase of infection.
T133 12222-12329 Sentence denotes Patients in this case series were generally young, with few comorbidities, and had benign clinical courses.
T134 12330-12540 Sentence denotes The pernio-like lesions in most patients developed either concurrently with, or after, COVID-19 symptoms, although 174 patients with confirmed or suspected COVID-19 presented only with pernio-like skin lesions.
T135 12541-12851 Sentence denotes Given these findings, at a time when there continues to be significant undetected community-based SARS-CoV-2 transmission, we propose that pernio-like lesions should be considered in testing criteria for COVID-19, with larger population-based epidemiologic studies needed to confirm or refute this association.
T136 12852-12973 Sentence denotes Given evolving understanding of COVID-19, clear public health messaging regarding these pernio-like lesions is paramount.
T137 12974-13141 Sentence denotes A key implication of COVID-19 cutaneous manifestations is the opportunity to recognize patients, especially asymptomatic ones, who are at risk for spreading infection.
T138 13142-13417 Sentence denotes The fact that many of our patients were otherwise asymptomatic and had not been tested for COVID-19 likely reflects limited availability of COVID-19 PCR testing at the start of the United States outbreak and variable state-by-state and country-by-country testing regulations.
T139 13418-13616 Sentence denotes In many locations, testing has been limited to sicker patients, selecting against testing of patients with mild disease, including those who may develop COVID-19–associated pernio-like skin lesions.
T140 13617-13751 Sentence denotes Also important is our ability to reassure the public regarding the relatively benign clinical course observed in most of our patients.
T141 13752-13807 Sentence denotes Lesions in this series resolved in a median of 2 weeks.
T142 13808-13986 Sentence denotes This duration is likely an underestimate, because the clinical courses of many patients are ongoing, and the data were only available for patients with completed disease courses.
T143 13987-14113 Sentence denotes Questions remain about patients who presented with pernio-like changes and presumed COVID-19 who were ultimately PCR negative.
T144 14114-14336 Sentence denotes Explanations for these patients include (1) findings were not COVID-19-related, (2) false-negative test results, or (3) testing occurred after viral clearance, with pernio-like lesions representing a late clinical finding.
T145 14337-14585 Sentence denotes Although multiple possibilities exist, reports from Europe of pernio-like lesions during the COVID-19 surge suggest a true association,1 , 4 , 5 with pernio-like findings most commonly appearing in younger patients and later in the disease course.1
T146 14586-14718 Sentence denotes New developments in COVID-19 antibody testing may further clarify the timing of pernio-like lesions in the COVID-19 clinical course.
T147 14719-14832 Sentence denotes Of the 20 patients known to have antibody testing (IgM, IgG, unspecified, or both), only 6 (30%) tested positive.
T148 14833-14890 Sentence denotes Two of these patients were PCR negative but IgM positive.
T149 14891-15275 Sentence denotes Early studies have suggested that for antibody response to SARS-CoV-2, IgM peaks at day 28 whereas IgG peaks at day 49 after the onset of illness.7 Although there is a possibility that IgM positivity represents a false positive, if reliable, it instead supports the theory that antibody testing would be an important part of the evaluation of pernio-like lesions to rule out COVID-19.
T150 15276-15478 Sentence denotes Further, if pernio is indeed a later disease course phenomenon in at least a subset of patients, then it may be prudent to repeat antibody testing and/or seek delayed IgG testing for suspected patients.
T151 15479-15646 Sentence denotes We must critically examine with further investigation why some patients with COVID-19–associated pernio-like lesions might test negative with current antibody testing.
T152 15647-15935 Sentence denotes Immunocompromised patients may fail to generate antibodies, but most patients with COVID-19–associated pernio-like lesions are otherwise healthy young patients whose skin lesions developed late in their course with theoretically sufficient time to generate IgM or IgG antibodies, or both.
T153 15936-15976 Sentence denotes There are several possible explanations.
T154 15977-16059 Sentence denotes Certainly, some patients may have new-onset pernio from other non–COVID-19 causes.
T155 16060-16236 Sentence denotes That may be true for some of these patients, but given the large number of new reports of pernio coincidentally with the COVID-19 pandemic, it is unlikely to explain all cases.
T156 16237-16457 Sentence denotes Some patients in the registry with negative antibodies had clinical histories predictive of high pretest probability; for example, a physician caring for COVID-19 patients in Milan and a child with a PCR-positive parent.
T157 16458-16710 Sentence denotes One possibility is false-negative test results, because there is significant variability in the sensitivity and specificity of current tests on the market.8 , 9 It is also possible that many patients with COVID-19 may have a delayed antibody responses.
T158 16711-17102 Sentence denotes Another, more worrisome, explanation is that the antibody response in patients with relatively mild disease tends not to be as brisk.7 , 10 This explanation is concerning, because it would both question the validity of our current antibody testing and suggest that patients with mild or asymptomatic disease may not generate antibodies (and possible immunity) upon infection with SARS-Cov-2.
T159 17103-17350 Sentence denotes Finally, reliable testing combined with coordination of timing of these skin changes with COVID-19 PCR, IgG, and IgM testing results is imperative to better establish self-isolation recommendations for patients presenting with pernio-like lesions.
T160 17351-17453 Sentence denotes There are multiple potential pathophysiologic mechanisms underpinning pernio-like lesions in COVID-19.
T161 17454-17960 Sentence denotes In nonepidemic settings, pernio is often idiopathic or related to underlying disease (eg, systemic lupus erythematosus or antiphospholipid antibody syndrome), and cannot easily be ascertained with histopathology alone.11 The histopathology reported for 1 of the COVID-19 PCR-positive patients, as well as 4 of 6 patients with suspected COVID-19, demonstrated features consistent with pernio without evidence of vascular damage, suggesting COVID-19–associated pernio-like lesions may be simply inflammatory.
T162 17961-18159 Sentence denotes The other 2 of 6 patients with suspected COVID-19 with histopathology reported vascular changes, including lymphocytic vasculitis, which can sometimes be seen in conjunction with variants of pernio.
T163 18160-18286 Sentence denotes Indeed, interferon response to viral infection appears to be a clue why some patients do poorly while others fare well.12 , 13
T164 18287-18774 Sentence denotes Less likely, but worthy of consideration, is that prothrombotic coagulopathy may be a contributing factor, as suggested by COVID-19 cases complicated by venous thromboembolism, pathologic reports of microvascular thrombosis,14 and laboratory abnormalities including elevated D-dimer and high fibrinogen.15, 16, 17 Furthermore, antiphospholipid antibodies have been implicated in a small case series of patients acutely ill with COVID-1918 and have previously been associated with pernio.
T165 18775-18990 Sentence denotes With greater clinical and pathologic correlation, we hope to better understand the pathophysiology, including understanding how, if at all, hypercoagulability plays a role in COVID-19–associated pernio-like lesions.
T166 18991-19149 Sentence denotes Importantly, although young patients with COVID-19 have presented with stroke, we are not aware of any cases of concomitant pernio-like lesions and strokes.19
T167 19150-19269 Sentence denotes Limitations of this case series include incomplete testing for COVID-19, especially in otherwise asymptomatic patients.
T168 19270-19347 Sentence denotes We are also unable to estimate the incidence or prevalence of this condition.
T169 19348-19401 Sentence denotes There may be confirmation bias in reporting of cases.
T170 19402-19600 Sentence denotes In addition, the background incidence of pernio from other causes in March and April is not well documented.6 We cannot exclude an epiphenomenon, because this case series cannot establish causation.
T171 19601-19726 Sentence denotes Future studies are needed to assess the histopathology of pernio-like lesions to inform understanding of the disease process.
T172 19728-19738 Sentence denotes Conclusion
T173 19739-19824 Sentence denotes Our case series demonstrates pernio-like skin lesions as a manifestation of COVID-19.
T174 19825-20086 Sentence denotes Patients with pernio-like lesions of COVID-19 may still be infectious and pose a public health risk, because skin lesions developed in at least 4 patients in this report before COVID-19 PCR confirmation, and the lesions developed in 14 while still PCR positive.
T175 20087-20245 Sentence denotes We propose that pernio-like lesions be added to the testing criteria for COVID-19 and prompt consideration of testing for both PCR and IgM and IgG antibodies.
T176 20246-20433 Sentence denotes This information will be critical to understanding the significance of these cutaneous lesions and empowering physicians and other health care providers to counsel patients appropriately.
T177 20435-20826 Sentence denotes We would like to thank Drs Philippe Dieude, Cynthia Yalowitz, Rachel Hub, Emily Arch, Ambrose Su, and Haydee Knott for providing photographs, Drs Rina Allawh, Graeme Lipper, Lynda Kauls, Lee Albert, Shannon Keiser, and Sarah Smilow for providing pathology, Dr Mariko Yasuda for her input on pathophysiologic mechanisms, and Dr Marlys Fassett for her contributions regarding antibody testing.
T178 20827-21013 Sentence denotes We would like to thank the American Academy of Dermatology Ad Hoc Task Force on COVID-19 and staff at the American Academy of Dermatology for their logistical and administrative support.
T179 21014-21128 Sentence denotes We would like to thank the International League of Dermatological Societies for their international collaboration.
T180 21129-21245 Sentence denotes We also appreciate the COVID-19 Global Rheumatology Alliance for sharing their experience with registry development.
T181 21246-21262 Sentence denotes Funding sources:
T182 21263-21268 Sentence denotes None.
T183 21269-21291 Sentence denotes Conflicts of interest:
T184 21292-21440 Sentence denotes Drs Freeman, Lipoff, Rosenbach, Kovarik, Takeshita, Hruza, and Fox are part of the American Academy of Dermatology (AAD) Covid-19 Ad Hoc Task Force.
T185 21441-21520 Sentence denotes Dr French is president of the International League of Dermatological Societies.
T186 21521-21569 Sentence denotes Dr Hruza is immediate past president of the AAD.
T187 21570-21608 Sentence denotes Dr Thiers is the president of the AAD.
T188 21609-21665 Sentence denotes Author McMahon has no conflicts of interest to disclose.
T189 21666-21686 Sentence denotes IRB approval status:
T190 21687-21873 Sentence denotes The registry was reviewed by the Partners Healthcare (Massachusetts General Hospital) Institutional Review Board and was determined to not meet the definition of Human Subjects Research.
T191 21874-21914 Sentence denotes Reprints not available from the authors.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 2523-2533 Phenotype denotes chilblains http://purl.obolibrary.org/obo/HP_0009710
T2 6168-6172 Phenotype denotes Pain http://purl.obolibrary.org/obo/HP_0012531
T3 6224-6232 Phenotype denotes Pruritus http://purl.obolibrary.org/obo/HP_0000989
T4 7116-7121 Phenotype denotes Cough http://purl.obolibrary.org/obo/HP_0012735
T5 7161-7169 Phenotype denotes Headache http://purl.obolibrary.org/obo/HP_0002315
T6 7208-7219 Phenotype denotes Sore throat http://purl.obolibrary.org/obo/HP_0033050
T7 7259-7264 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T8 7305-7312 Phenotype denotes Malaise http://purl.obolibrary.org/obo/HP_0012378
T9 7354-7373 Phenotype denotes Shortness of breath http://purl.obolibrary.org/obo/HP_0002098
T10 7670-7694 Phenotype denotes Obstructive lung disease http://purl.obolibrary.org/obo/HP_0006536
T11 7737-7749 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T12 7848-7874 Phenotype denotes Inflammatory bowel disease http://purl.obolibrary.org/obo/HP_0002037
T13 9764-9769 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T14 9777-9785 Phenotype denotes headache http://purl.obolibrary.org/obo/HP_0002315
T15 9793-9804 Phenotype denotes sore throat http://purl.obolibrary.org/obo/HP_0033050
T16 9816-9821 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T17 10529-10541 Phenotype denotes acrocyanosis http://purl.obolibrary.org/obo/HP_0001063
T18 10569-10581 Phenotype denotes desquamation http://purl.obolibrary.org/obo/HP_0040189
T19 11094-11104 Phenotype denotes dermatitis http://purl.obolibrary.org/obo/HP_0011123
T20 11642-11652 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T21 11685-11692 Phenotype denotes blister http://purl.obolibrary.org/obo/HP_0008066
T22 11723-11733 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T23 11788-11798 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T24 17544-17572 Phenotype denotes systemic lupus erythematosus http://purl.obolibrary.org/obo/HP_0002725
T25 17576-17601 Phenotype denotes antiphospholipid antibody http://purl.obolibrary.org/obo/HP_0003613
T26 18080-18090 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T27 18351-18363 Phenotype denotes coagulopathy http://purl.obolibrary.org/obo/HP_0003256
T28 18447-18462 Phenotype denotes thromboembolism http://purl.obolibrary.org/obo/HP_0001907
T29 18518-18542 Phenotype denotes laboratory abnormalities http://purl.obolibrary.org/obo/HP_0001939
T30 18553-18569 Phenotype denotes elevated D-dimer http://purl.obolibrary.org/obo/HP_0033106
T31 18614-18641 Phenotype denotes antiphospholipid antibodies http://purl.obolibrary.org/obo/HP_0003613
T32 18915-18933 Phenotype denotes hypercoagulability http://purl.obolibrary.org/obo/HP_0100724
T33 19062-19068 Phenotype denotes stroke http://purl.obolibrary.org/obo/HP_0001297

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 12-24 Disease denotes skin lesions MESH:D012871
3 41-49 Disease denotes COVID-19 MESH:C000657245
6 200-235 Disease denotes coronavirus infectious disease 2019 MESH:C000657245
7 237-245 Disease denotes COVID-19 MESH:C000657245
9 367-375 Disease denotes COVID-19 MESH:C000657245
17 677-685 Disease denotes COVID-19 MESH:C000657245
18 822-830 Disease denotes COVID-19 MESH:C000657245
19 876-884 Disease denotes COVID-19 MESH:C000657245
20 933-941 Disease denotes COVID-19 MESH:C000657245
21 1018-1026 Disease denotes COVID-19 MESH:C000657245
22 1081-1089 Disease denotes COVID-19 MESH:C000657245
23 1195-1203 Disease denotes COVID-19 MESH:C000657245
26 1638-1646 Disease denotes COVID-19 MESH:C000657245
27 1647-1656 Disease denotes infection MESH:D007239
29 1859-1867 Disease denotes COVID-19 MESH:C000657245
31 2021-2029 Disease denotes COVID-19 MESH:C000657245
41 2090-2125 Disease denotes coronavirus infectious disease 2019 MESH:C000657245
42 2127-2135 Disease denotes COVID-19 MESH:C000657245
43 2208-2216 Disease denotes COVID-19 MESH:C000657245
44 2266-2286 Disease denotes urticarial eruptions MESH:D003875
45 2292-2309 Disease denotes vesicular lesions MESH:D012872
46 2354-2370 Disease denotes viral infections MESH:D001102
47 2493-2501 Disease denotes COVID-19 MESH:C000657245
48 2827-2835 Disease denotes COVID-19 MESH:C000657245
49 3023-3031 Disease denotes COVID-19 MESH:C000657245
53 3119-3127 Disease denotes COVID-19 MESH:C000657245
54 3736-3744 Disease denotes COVID-19 MESH:C000657245
55 3917-3925 Disease denotes COVID-19 MESH:C000657245
80 4888-4896 Disease denotes COVID-19 MESH:C000657245
81 4946-4954 Disease denotes COVID-19 MESH:C000657245
82 4984-4992 Disease denotes COVID-19 MESH:C000657245
83 5022-5030 Disease denotes COVID-19 MESH:C000657245
84 6168-6172 Disease denotes Pain MESH:D010146
85 6224-6232 Disease denotes Pruritus MESH:D011537
86 6370-6378 Disease denotes COVID-19 MESH:C000657245
87 6436-6444 Disease denotes COVID-19 MESH:C000657245
88 6514-6522 Disease denotes COVID-19 MESH:C000657245
89 6574-6582 Disease denotes COVID-19 MESH:C000657245
90 6684-6692 Disease denotes COVID-19 MESH:C000657245
91 6814-6822 Disease denotes COVID-19 MESH:C000657245
92 6875-6883 Disease denotes COVID-19 MESH:C000657245
93 6963-6971 Disease denotes COVID-19 MESH:C000657245
94 6972-6982 Disease denotes infections MESH:D007239
95 7042-7050 Disease denotes COVID-19 MESH:C000657245
96 7116-7121 Disease denotes Cough MESH:D003371
97 7161-7169 Disease denotes Headache MESH:D006261
98 7259-7264 Disease denotes Fever MESH:D005334
99 7354-7373 Disease denotes Shortness of breath MESH:D004417
100 7414-7422 Disease denotes COVID-19 MESH:C000657245
101 7682-7694 Disease denotes lung disease MESH:D008171
102 7737-7749 Disease denotes Hypertension MESH:D006973
103 7848-7874 Disease denotes Inflammatory bowel disease MESH:D015212
105 4815-4823 Disease denotes COVID-19 MESH:C000657245
107 8026-8034 Disease denotes COVID-19 MESH:C000657245
109 8135-8143 Disease denotes COVID-19 MESH:C000657245
112 4317-4325 Disease denotes COVID-19 MESH:C000657245
113 4538-4546 Disease denotes COVID-19 MESH:C000657245
119 8384-8392 Disease denotes COVID-19 MESH:C000657245
120 8947-8955 Disease denotes COVID-19 MESH:C000657245
121 9078-9086 Disease denotes COVID-19 MESH:C000657245
122 9137-9145 Disease denotes COVID-19 MESH:C000657245
123 9488-9496 Disease denotes COVID-19 MESH:C000657245
132 10170-10176 Chemical denotes oxygen MESH:D010100
133 9667-9675 Disease denotes COVID-19 MESH:C000657245
134 9764-9769 Disease denotes cough MESH:D003371
135 9777-9785 Disease denotes headache MESH:D006261
136 9793-9804 Disease denotes sore throat MESH:D010608
137 9816-9821 Disease denotes fever MESH:D005334
138 9947-9955 Disease denotes COVID-19 MESH:C000657245
139 9994-10002 Disease denotes COVID-19 MESH:C000657245
142 10825-10833 Disease denotes COVID-19 MESH:C000657245
143 10943-10951 Disease denotes COVID-19 MESH:C000657245
145 10529-10541 Disease denotes acrocyanosis
152 11094-11104 Disease denotes dermatitis MESH:D003872
153 11132-11161 Disease denotes deep lymphocytic inflammation MESH:D007249
154 11642-11652 Disease denotes vasculitis MESH:D014657
155 11698-11733 Disease denotes small vessel lymphocytic vasculitis MESH:C565222
156 11776-11798 Disease denotes lymphocytic vasculitis MESH:C566008
157 11846-11854 Disease denotes necrosis MESH:D009336
164 12086-12094 Disease denotes COVID-19 MESH:C000657245
165 12211-12220 Disease denotes infection MESH:D007239
166 12417-12425 Disease denotes COVID-19 MESH:C000657245
167 12486-12494 Disease denotes COVID-19 MESH:C000657245
168 12527-12539 Disease denotes skin lesions MESH:D012871
169 12745-12753 Disease denotes COVID-19 MESH:C000657245
177 12884-12892 Disease denotes COVID-19 MESH:C000657245
178 12995-13003 Disease denotes COVID-19 MESH:C000657245
179 13131-13140 Disease denotes infection MESH:D007239
180 13233-13241 Disease denotes COVID-19 MESH:C000657245
181 13282-13290 Disease denotes COVID-19 MESH:C000657245
182 13571-13579 Disease denotes COVID-19 MESH:C000657245
183 13603-13615 Disease denotes skin lesions MESH:D012871
187 14071-14079 Disease denotes COVID-19 MESH:C000657245
188 14176-14184 Disease denotes COVID-19 MESH:C000657245
189 14430-14438 Disease denotes COVID-19 MESH:C000657245
193 14606-14614 Disease denotes COVID-19 MESH:C000657245
194 14693-14701 Disease denotes COVID-19 MESH:C000657245
195 15266-15274 Disease denotes COVID-19 MESH:C000657245
199 15556-15564 Disease denotes COVID-19 MESH:C000657245
200 15730-15738 Disease denotes COVID-19 MESH:C000657245
201 15813-15825 Disease denotes skin lesions MESH:D012871
208 16043-16051 Disease denotes COVID-19 MESH:C000657245
209 16181-16189 Disease denotes COVID-19 MESH:C000657245
210 16391-16399 Disease denotes COVID-19 MESH:C000657245
211 16663-16671 Disease denotes COVID-19 MESH:C000657245
212 17076-17085 Disease denotes infection MESH:D007239
213 17193-17201 Disease denotes COVID-19 MESH:C000657245
223 17444-17452 Disease denotes COVID-19 MESH:C000657245
224 17544-17610 Disease denotes systemic lupus erythematosus or antiphospholipid antibody syndrome MESH:D008180
225 17716-17724 Disease denotes COVID-19 MESH:C000657245
226 17790-17798 Disease denotes COVID-19 MESH:C000657245
227 17865-17880 Disease denotes vascular damage MESH:D000783
228 17893-17901 Disease denotes COVID-19 MESH:C000657245
229 18002-18010 Disease denotes COVID-19 MESH:C000657245
230 18068-18090 Disease denotes lymphocytic vasculitis MESH:C566008
231 18191-18206 Disease denotes viral infection MESH:D001102
242 18337-18363 Disease denotes prothrombotic coagulopathy MESH:D001778
243 18410-18418 Disease denotes COVID-19 MESH:C000657245
244 18440-18462 Disease denotes venous thromboembolism MESH:D054556
245 18500-18510 Disease denotes thrombosis MESH:D013927
246 18715-18723 Disease denotes COVID-19 MESH:C000657245
247 18915-18933 Disease denotes hypercoagulability MESH:D019851
248 18950-18958 Disease denotes COVID-19 MESH:C000657245
249 19033-19041 Disease denotes COVID-19 MESH:C000657245
250 19062-19068 Disease denotes stroke MESH:D020521
251 19139-19146 Disease denotes strokes MESH:D020521
253 19213-19221 Disease denotes COVID-19 MESH:C000657245
260 19780-19792 Disease denotes skin lesions MESH:D012871
261 19815-19823 Disease denotes COVID-19 MESH:C000657245
262 19862-19870 Disease denotes COVID-19 MESH:C000657245
263 19934-19946 Disease denotes skin lesions MESH:D012871
264 20002-20010 Disease denotes COVID-19 MESH:C000657245
265 20160-20168 Disease denotes COVID-19 MESH:C000657245

2_test

Id Subject Object Predicate Lexical cue
32479979-32339703-55085346 14480-14481 32339703 denotes 5
32479979-9104949-55085347 17672-17674 9104949 denotes 11
32479979-28844088-55085348 18284-18286 28844088 denotes 13
32479979-32073213-55085349 18590-18592 32073213 denotes 15
32479979-32105632-55085350 18594-18596 32105632 denotes 16
32479979-32268022-55085351 18721-18725 32268022 denotes 1918
32479979-32343504-55085352 19147-19149 32343504 denotes 19
32479979-24485134-55085353 19510-19511 24485134 denotes 6